| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.18 | 5e-07 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.17 | 8e-07 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.17 | 9e-07 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.16 | 1e-06 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.15 | 1e-06 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.17 | 1e-06 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.15 | 2e-06 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.16 | 2e-06 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.18 | 2e-06 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.23 | 2e-06 |